Pear Therapeutics receives FDA Breaktrough Device Designation
Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), announ…
Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), announ…
We have written not long ago that Big Data is revolutionizing the health care delivery systems, increased by the omnipresence of digital dev…
Research Highlights: A novel software algorithm developed for wearable devices, such as smartwatches and fitness trackers, was able to detect irreg…
In the IASP 2021 Virtual World Congress of Pain, the results from Orion Corporation’s pilot study ‘VIRPI’ were announced. The novel treatment, a digit…
The hybrid session, held in partnership with Plexus Ventures and Healthware Group and focused on digital therapeutics (DTx) endorsement by pharma comp…
Article originally posted on transcarent.com by Glen Tullman - Executive Chairman and CEO, Transcarent on October 13, 2021 "We tend to overestimate…
Why is measuring mental well-being becoming critical and how can we make it as simple as checking temperature? An article written by kenkou GmbH …
Article originally published on zs.com by Pete Masloski on July 14, 2021 Digital health is maturing and accelerating like never before, with a wide…
Spatial Partners with HealthTunes and Catalyst by Wellstar to Leverage the Healing Power of Sound to Help Frontline Healthcare Workers Reduce Stress &…
Tanja Dowe is the CEO of Debiopharm Innovation Fund, the strategic investment arm of the Swiss pharmaceutical company Debiopharm. The Fund invests in …